Nursing · Independent exam preparation
ACHPN Preparation Guide: Advanced Hospice and Palliative Nursing Study Guide
Practise advanced assessment, symptom decisions, serious-illness communication, and ethical care through 60 ACHPN concepts, cases, and original learning drills.
By CertMedbry · Updated 27 October 2026
Recognize reversible distress, distinguish treatment benefit from burden, prepare surrogates, and connect symptom decisions to patient goals. This selective guide develops 60 advanced practice concepts across all four domains of HPCC's 2026 ACHPN outline, including renal disease management, population-specific assessment, and palliative emergencies. The official Detailed Content Outline and task statements define the full examination scope; these concepts are a focused starting point, with cancer-specific evidence identified where relevant.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which credential and professional pathway does this guide cover?
The Advanced Certified Hospice and Palliative Nurse (ACHPN) examination is for experienced hospice and palliative APRNs functioning as NPs or CNSs. Both roles lead to the same ACHPN credential; the handbook does not identify separate NP and CNS examination variants. CHPN is a separate registered nurse credential, and CHPPN is a separate pediatric nursing credential.
ACHPN | HPCC · HPCC 2026 ACHPN Candidate Handbook hosted by PSI
How many questions are scored, and how long is the examination?
The 2026 handbook specifies 175 multiple-choice questions: 150 equally weighted scored questions and 25 unscored pretest questions interspersed throughout the examination. The time allowance is three and one-half hours. Pretest performance does not affect the score.
What item style and delivery methods are verified?
Each question has four response alternatives and one best response. The computer-based examination is available at PSI test centers or through live remote proctoring. It is not adaptive: questions do not become more difficult in response to previous answers. Within the time limit, candidates may revisit questions, change responses, and bookmark questions for review.
HPCC 2026 ACHPN Candidate Handbook hosted by PSI · ACHPN | HPCC
Which blueprint edition applies to this guide?
This guide uses the Detailed Content Outline on page 30 of the 2026 ACHPN Candidate Handbook, dated December 2025, selected for the October 10, 2026 study reference date. Its examination content is based on the 2021 national job analysis. HPCC separately links a prospective 2027 outline; its content and weights are not applied to this guide.
2026 ACHPN Candidate Handbook — December 2025 · HPCC 2026 ACHPN Candidate Handbook hosted by PSI · ACHPN | HPCC
How are the official domains weighted?
HPCC publishes scored-question counts: Assessment and Data Collection, 44; Intervention and Management, 32; Education and Communication, 36; Professionalism and Practice, 38. Dividing by 150 gives approximately 29.33%, 21.33%, 24%, and 25.33%, respectively. This guide allocates its concepts 18/13/14/15 and its questions and flashcards 6/4/5/5. The official outline and task statements remain the full scope.
What does the passing score mean?
The handbook reports a scaled-score range of 200–800 and a minimum passing scaled score of 500. Equating adjusts for differences among examination forms, so 500 does not mean a fixed percentage of questions answered correctly. These original learning questions provide practice and explanation; their results do not predict certification success.
What eligibility and jurisdiction distinctions matter?
The issuer identifies graduate NP or CNS preparation, advanced practice licensure or its Canadian equivalent, specified advanced coursework and practicum preparation, and recent hospice and palliative advanced practice experience. The current issuer page and handbook differ in some licensing and transcript wording, so applicants should follow HPCC's current application requirements. ACHPN certification does not independently establish prescribing, billing, or practice authority in every jurisdiction.
ACHPN | HPCC · HPCC 2026 ACHPN Candidate Handbook hosted by PSI
Is initial certification the same as ACHPN renewal?
No. This guide targets the initial certification examination. The 2026 handbook describes renewal through ACHPN Hospice and Palliative Accrual for Recertification, including a Situational Judgment Exercise, practice requirements, and professional development activities. That renewal exercise is not the initial four-option multiple-choice examination.
ACHPN is HPCC's advanced practice hospice and palliative nursing credential for eligible nurse practitioners and clinical nurse specialists. This independently authored guide addresses initial ACHPN certification under the 2026 handbook and does not substitute content from HPCC's separate RN or pediatric credentials.
Outline used: 2026 ACHPN Candidate Handbook, dated December 2025; Detailed Content Outline on page 30, based on the 2021 national job analysis. Selected for the user-facing date 2026-10-10. The workbook label matches the official credential; the assigned slug is preserved. HPCC separately links a prospective 2027 outline.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Assessment and Data Collection44/150 scored questions (29.33%, calculated)
1.How does a pain history identify the next clinical decision?
A useful pain history connects location, quality, intensity, timing, triggers, relief, and functional interference with the underlying illness and current treatment. Record scheduled and rescue medication use, benefit, adverse effects, and the patient's acceptable comfort target. A numerical score alone cannot distinguish disease progression from treatment failure or toxicity. New focal pain, a changed pattern, or associated neurologic symptoms should redirect assessment rather than automatically trigger a larger opioid dose.
Apply it
A patient reports pain of seven despite medication. Clarifying questions reveal brief severe pain only during transfers, with comfortable rest and preserved alertness. Assess movement-related pain and transfer technique before treating the report as continuous uncontrolled baseline pain.
Common pitfall: Increasing the scheduled opioid solely because of the highest reported score may worsen resting sedation while leaving a predictable activity-related pain trigger insufficiently addressed.
2.Which findings distinguish nociceptive from neuropathic pain?
Nociceptive pain arises from activation of pain receptors by tissue injury or inflammation; somatic pain is often localized, whereas visceral pain may be diffuse or referred. Neuropathic pain results from injury or disease affecting the somatosensory system and may involve burning, electric sensations, allodynia, or sensory loss. Mixed mechanisms are common in cancer. Mechanism guides adjunct selection and further examination, but descriptive words alone do not establish the diagnosis without an anatomically coherent pattern.
Apply it
After cancer treatment, a patient describes burning feet, painful contact from bedsheets, and reduced distal sensation. This pattern supports a neuropathic component and prompts medication and functional assessment rather than assuming all pain reflects new tumor growth.
Common pitfall: Calling every severe pain neuropathic confuses intensity with mechanism. Conversely, an opioid response does not prove that pain has a purely nociceptive origin.
3.How do incident pain and end-of-dose failure differ?
Breakthrough pain is a transient exacerbation superimposed on otherwise controlled background pain. Incident pain follows a trigger, such as movement or a procedure, and may be predictable. End-of-dose failure repeatedly appears as a scheduled analgesic wears off, suggesting that the baseline regimen needs reassessment. Document timing relative to activity and medication administration, episode duration, and rescue response. These patterns identify different treatment problems even when patients use the same intensity score.
Apply it
One patient's pain returns before every scheduled dose, while another has brief pain only during wound care. Compare medication timing with symptoms: the first pattern suggests inadequate duration of baseline coverage, while the second supports anticipatory procedural planning.
Common pitfall: Treating every flare with the same rescue-only strategy can conceal an inadequate baseline regimen. Increasing baseline medication indiscriminately can also overtreat brief, predictable incident pain.
4.How should pain be assessed when speech is limited?
Attempt supported self-report first, using simple questions, communication aids, or consistent yes-or-no responses. If reliable self-report is unavailable, combine a suitable observational instrument with facial expression, guarding, vocalization, movement, examination, and knowledge of likely painful conditions. Caregiver observations can establish baseline behavior. Physiologic changes are nonspecific and cannot independently quantify pain. Reassess behavior and comfort after an intervention while also considering delirium, fear, urinary discomfort, or other explanations for distress.
Apply it
A patient with advanced cognitive impairment grimaces during turning but rests quietly afterward. Ask the caregiver whether this behavior is new, examine for painful causes, use an appropriate observational approach, and compare behavior after a comfort intervention.
Common pitfall: Absence of a verbal complaint does not establish absence of pain. Equally, agitation alone does not prove pain or justify repeated analgesic escalation without reassessment.
5.Which findings suggest opioid neurotoxicity?
Opioid neurotoxicity may include delirium, hallucinations, myoclonus, and increased pain sensitivity. Risk can increase when drug or metabolite clearance falls, particularly with renal dysfunction, dehydration, or intercurrent illness. Review the opioid, dose changes, co-medications, renal function, and temporal relationship to symptoms. Worsening pain accompanied by new neuroexcitation should prompt evaluation for toxicity and alternative causes; escalating the same opioid may intensify the problem rather than improve comfort.
Apply it
A patient receiving morphine develops hallucinations and jerking movements after several days of poor intake and declining kidney function. Despite reported pain, assess medication accumulation and other delirium contributors before deciding that disease progression requires a higher morphine dose.
Common pitfall: Myoclonus and hallucinations are not ordinary evidence of undertreated pain. Their appearance does not establish toxicity alone, but it changes the differential and prescribing decision.
6.What makes an acute cognitive change consistent with delirium?
Delirium involves an acute change in attention, awareness, and cognition that commonly fluctuates over hours or across the day. Patients may be agitated, unusually quiet, or alternate between these patterns. Establish the previous cognitive baseline and ask caregivers about onset and fluctuation. A quiet, sleepy patient may have hypoactive delirium rather than simple fatigue. The discriminating features are the new change and impaired attention, not merely hallucinations or disruptive behavior.
Apply it
A previously conversational patient becomes withdrawn in the morning and restless at night, repeatedly losing track of questions. Ask about baseline cognition and recent medication or illness changes, then evaluate for delirium rather than labeling the behavior a personality change.
Common pitfall: Screening only visibly agitated patients misses hypoactive presentations. Chronic dementia also does not exclude superimposed delirium when attention or behavior changes abruptly from baseline.
7.How are potentially reversible delirium contributors prioritized?
Delirium assessment links onset to medication exposure, infection, dehydration, metabolic disturbance, organ dysfunction, pain, and environmental disruption. Several contributors may coexist. Review recent changes and examine the patient before selecting investigations whose results could alter goal-concordant treatment. In advanced illness, reversibility and treatment burden vary; delirium should not automatically be declared terminal. The useful decision is which plausible contributor can be addressed with a reasonable prospect of improving comfort or meaningful interaction.
Apply it
An intermittently confused patient started a new sedating medicine and has poor intake. The patient values remaining conversational. Review medication effects, hydration, examination findings, and feasible corrective treatment before ordering an indiscriminate panel of burdensome tests.
Common pitfall: Assuming that every cognitive change is irreversible dying can miss treatable suffering. Assuming every abnormal laboratory result requires correction can impose burdens without improving the patient's goals.
Delirium: Cancer Treatment Side Effect · Last Days of Life (PDQ) — Health Professional Version
8.Why can severe breathlessness occur with a normal oxygen saturation?
Breathlessness is a subjective experience influenced by respiratory effort, disease burden, perception, emotion, and context. Oxygen saturation measures oxygenation, not the intensity of air hunger. Assess the patient's report, onset, respiratory pattern, associated symptoms, examination findings, functional effect, and possible reversible causes. A normal saturation should not invalidate distress or end assessment. Conversely, a saturation value alone does not determine whether supplemental oxygen will improve comfort in a patient without hypoxemia.
Apply it
A patient with advanced cancer reports frightening air hunger despite a normal saturation. Assess work of breathing and potential causes, ask about panic and positioning, and plan symptom relief rather than reassuring the patient that the normal reading excludes distress.
Common pitfall: Equating oxygen saturation with comfort can leave breathlessness untreated. Equating every complaint of breathlessness with hypoxemia can lead to equipment burden without demonstrated symptomatic benefit.
9.Which new pain findings require an urgent neurologic assessment?
New back pain in a patient with cancer becomes especially concerning when accompanied by weakness, sensory change, gait difficulty, or new bladder or bowel dysfunction. These findings raise concern for spinal cord or cauda equina involvement rather than uncomplicated musculoskeletal pain. Determine onset, progression, neurologic deficits, and treatment goals promptly. The assessment must identify a time-sensitive threat to function; analgesia alone does not address a potentially compressive lesion or establish a safe disposition.
Apply it
A patient with vertebral metastases reports new leg weakness and difficulty initiating urination alongside worsening back pain. Perform an urgent focused neurologic assessment and activate the agreed emergency pathway instead of arranging a routine follow-up after analgesic adjustment.
Common pitfall: A known history of chronic back pain can create false reassurance. New neurologic or sphincter findings change the urgency even when pain intensity seems familiar.
Recommendations | Spinal metastases and metastatic spinal cord compression | Guidance | NICE
10.How are conflicting PPSv2 dimensions reconciled?
PPSv2 considers ambulation, activity and disease, self-care, intake, and consciousness. Assess what the patient can do, rather than only what they happen to be doing. Begin with ambulation and work left to right across the remaining dimensions. Leftward dimensions take precedence, while clinical judgment resolves discrepancies by selecting the best horizontal fit across the whole pattern. This permits judgment about adjacent levels; it is not a rigid mobility-only rule. Never sum or average dimension scores.
Apply it
A patient remains in bed by preference but can walk and perform personal care. Establish actual capability before scoring. If dimensions suggest different levels, apply leftward precedence and clinical judgment to choose the best horizontal fit.
Common pitfall: Averaging dimension scores, selecting the lowest isolated finding, or treating observed inactivity as incapacity misapplies the tool. A PPSv2 level is not an exact survival prediction.
Questions and Answers, Instructions and Definitions for Use of PPSv2 — July 2020
11.How should assessment and treatment planning differ for a frail older adult?
Compared with a younger adult with preserved organ function, a frail older adult may have reduced renal or hepatic clearance, greater medication sensitivity, polypharmacy, sensory barriers, and less reserve for adverse effects. Assess cognition, falls, self-care, actual medication use, and organ function alongside symptom intensity. Start susceptible medicines cautiously and reassess both relief and function. Age alone does not establish incapacity or justify undertreatment. Tricyclic anticholinergic effects, opioid accumulation, and NSAID renal or gastrointestinal harms require particular attention.
Apply it
Two adults report similar symptoms, but the older patient has declining kidney function, recent falls, and several sedating medicines. Review interactions and clearance, establish cognitive and mobility baselines, and use slower titration with earlier reassessment rather than copying the younger patient's regimen.
Common pitfall: Chronologic age cannot substitute for individual assessment. Avoid both automatic dose equivalence across patients and withholding effective symptom treatment solely because the patient is older.
12.How should reduced intake near death be interpreted?
Reduced appetite, swallowing ability, and intake commonly accompany advanced dying, but assessment should still consider oral discomfort, nausea, constipation, medication effects, and other potentially treatable contributors. Determine whether eating causes distress, whether swallowing is safe, and what the patient wants. Reduced intake is not automatically evidence of neglect or a correctable calorie deficit. The relevant distinction is between a burdensome symptom that can be relieved and a physiologic change for which forced intake may add discomfort.
Apply it
A dying patient turns away from meals but accepts small sips and mouth care. Assess oral comfort and swallowing, explain the illness-related change, and offer desired intake safely rather than using meal completion as the principal measure of care.
Common pitfall: Assuming that more calories will reverse the dying process can encourage coercive feeding. Also avoid overlooking a painful mouth or another treatable reason for reduced intake.
13.Which caregiver findings can make a home plan unsafe?
A feasible home plan depends on willingness, physical ability, understanding, emotional capacity, available help, and access to supplies and urgent support. Ask caregivers directly about sleep, lifting, medication responsibilities, finances, and tasks they cannot safely perform. Agreement with the patient's preference does not establish capacity to provide all necessary care. Identify the gap between expected tasks and actual resources, then adapt services, equipment, education, or setting rather than interpreting exhaustion as lack of commitment.
Apply it
A spouse supports discharge home but has severe arthritis and no overnight help. Assess transfer demands, medication tasks, and available services. Revise the plan with equipment and additional support before assuming the spouse can provide continuous hands-on care.
Common pitfall: Asking only whether a caregiver wants the patient home can produce a misleading yes. Emotional commitment does not replace physical ability, practical resources, or respite.
HPCC 2026 ACHPN Candidate Handbook hosted by PSI · Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ)
14.How does spiritual assessment reveal sources of suffering and strength?
Spiritual assessment explores meaning, hope, connection, beliefs, practices, and concerns that influence illness experience and decisions. Begin with the patient's language and ask what sustains them or feels threatened. Religious affiliation alone does not identify preferences, distress, or desired support. A person may draw strength from community while also feeling abandoned or guilty. The clinical task is to recognize these concerns, clarify their effect on care, and offer appropriate interdisciplinary support without imposing the clinician's beliefs.
Apply it
A patient who identifies with a faith tradition says treatment feels like punishment. Ask what that belief means to them, whether it affects decisions, and whom they would welcome for support rather than assuming their religious community is already meeting the need.
Common pitfall: Recording an affiliation as a complete spiritual assessment misses individual experience. Automatically offering reassurance from the clinician's own beliefs may silence rather than relieve the patient's distress.
Communication in Cancer Care (PDQ) — Health Professional Version · HPCC 2026 ACHPN Candidate Handbook hosted by PSI
15.What should advance care planning establish beyond a document?
Advance care planning clarifies values, acceptable outcomes, treatment preferences, and who should speak if the patient cannot decide. Documents support this process but may not resolve a new clinical situation without interpretation. Ask what abilities matter most, what burdens are acceptable for a meaningful chance of benefit, and whether the surrogate understands those priorities. Revisit preferences as illness and experience change. A completed form is useful only when its meaning can guide current decisions.
Apply it
A patient has named a surrogate but never discussed prolonged dependence. Explore what independence and interaction mean to the patient, then invite the surrogate into a conversation connecting those values with possible future treatment decisions and uncertainty.
Common pitfall: Treating a signed form as the endpoint can leave surrogates unprepared. A general preference for comfort also needs interpretation in relation to the particular treatment and circumstances.
Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ)
16.How should decision-making ability be assessed when communication is difficult?
Difficulty speaking, hearing, or using the clinician's language does not itself establish inability to decide. Provide communication support and assess whether the patient can understand the relevant information, appreciate its personal implications, compare choices, and communicate a decision. The assessment concerns the specific decision and current condition. Delirium or medication effects may alter ability over time. A patient's disagreement with the recommended option is not, by itself, evidence that decision-making ability is absent.
Apply it
A patient with severe dysarthria consistently communicates by a letter board and explains the consequences of declining ventilation. Use the communication aid to assess the decision rather than transferring authority to family solely because speech is difficult.
Common pitfall: Confusing disability or an unpopular choice with incapacity undermines autonomy. Conversely, a clear statement of preference alone does not establish understanding of the decision's consequences.
Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ) · AMA Code of Medical Ethics: Withholding or Withdrawing Life-Sustaining Treatment
17.How should new jerking movements be assessed for seizure or myoclonus?
Myoclonus consists of brief, involuntary, shocklike muscle contractions; sustained rhythmic convulsions with impaired responsiveness suggest a seizure. Record onset, duration, awareness, breathing, and recovery between episodes. A convulsion lasting at least five minutes, or repeated convulsions without recovery of consciousness, requires immediate emergency treatment consistent with the patient's goals and individualized plan. Protect the airway, prevent injury, assess glucose when appropriate, and promptly administer prescribed benzodiazepine rescue treatment. NICE identifies buccal midazolam or rectal diazepam as community first-line options; intravenous lorazepam requires immediately available intravenous access and resuscitation facilities. These are clinical guidance recommendations, not examination rules. Review missed antiseizure medication, opioid accumulation, renal decline, metabolic abnormalities, and neurologic disease.
Apply it
A patient receiving morphine during renal decline initially has brief jerks while remaining conversational. Later, a generalized convulsion lasts two minutes, followed by another before consciousness returns. The absence of recovery makes this an emergency even though neither episode individually lasted five minutes. Summon the agreed help, protect breathing and safety, give prescribed rescue treatment, and evaluate glucose and medication contributors without delaying seizure treatment.
Common pitfall: Do not assume preserved awareness proves that all jerking is harmless or wait five minutes when convulsions recur without recovery. Avoid restraining the patient or placing objects in the mouth. Opioid rotation may address neurotoxicity after immediate stabilization, but it does not replace seizure rescue treatment.
Last Days of Life (PDQ) — Health Professional Version · Cancer Pain (PDQ) — Health Professional Version · HPCC 2026 ACHPN Candidate Handbook hosted by PSI · 7 Treating status epilepticus, repeated or cluster seizures, and prolonged seizures | Epilepsies in children, young people and adults | Guidance | NICE
18.Which patterns support recognition of imminent dying?
A cluster of progressive weakness, reduced intake, diminished responsiveness, altered breathing, reduced urine output, and circulatory changes may support recognition of the last days of life. Individual signs vary in timing and diagnostic value, and absence of a particular sign does not exclude dying. Interpret the pattern against the illness trajectory and possible reversible causes. Recognition should trigger comfort reassessment, practical preparation, and clear communication, while preserving uncertainty about the exact time remaining.
Apply it
A patient with sustained decline now takes only sips, responds briefly to voice, has scant urine, and develops irregular breathing. Explain that the combined pattern suggests approaching death, update comfort care, and help family members prepare for further change.
Common pitfall: Using one sign as a countdown can mislead families. Also avoid attributing a sudden isolated change to dying before considering a plausible reversible cause.
Intervention and Management32/150 scored questions (21.33%, calculated)
19.When does diagnostic testing offer meaningful palliative benefit?
A diagnostic test is useful when its result could change a treatment decision that matters to the patient's goals. Define the clinical question, likely findings, available responses, time to benefit, and procedural burden before ordering. Comfort-focused care can include testing when it enables symptom relief; it can also justify declining a test that will not change management. The decision turns on expected benefit and burden in this patient, not on a blanket rule about palliative status.
Apply it
A patient wants relief of painful urinary retention but declines hospitalization for disease-directed treatment. A focused assessment that could guide bladder decompression may offer direct comfort benefit, whereas extensive staging would not answer the immediate symptom-management question.
Common pitfall: Ordering tests from habit can create burdens without actionable benefit. Refusing every investigation because care is palliative can also deny a practical route to symptom relief.
HPCC 2026 ACHPN Candidate Handbook hosted by PSI · Last Days of Life (PDQ) — Health Professional Version
20.How does multimodal analgesia target neuropathic and bone pain differently?
Gabapentin is a possible adjunct for burning radicular pain: binding the alpha2delta subunit of voltage-gated calcium channels reduces neuronal excitability. Adjust it for renal function and titrate cautiously because sedation, dizziness, and ataxia can impair interaction and mobility. Focal painful bone metastasis warrants a separate assessment for palliative radiotherapy, which can relieve lesion-related pain without relying solely on systemic drug escalation. NSAIDs may help an inflammatory component but add renal and gastrointestinal risk. Reassess each intervention's specific benefit, cognitive effects, function, and time to benefit.
Apply it
A patient has burning radicular pain and a painful pelvic metastasis, stable moderate renal impairment, and a goal of remaining alert. Begin a cautiously titrated, renally adjusted gabapentin trial for the neuropathic component and coordinate radiotherapy assessment for focal bone pain. Maintain needed analgesia while awaiting benefit; avoid routine NSAID addition given renal risk.
Common pitfall: Gabapentin does not address the bone lesion itself, and radiotherapy does not provide immediate rescue analgesia. Increasing several sedating medicines together obscures which treatment helps or harms.
21.Why does opioid rotation require more than an equianalgesic calculation?
Opioid rotation may improve the balance between analgesia and adverse effects when the current agent is ineffective or poorly tolerated. Equianalgesic estimates are starting references, not guarantees of an individual's response. Incomplete cross-tolerance, organ function, frailty, route, current exposure, and the reason for switching affect the initial regimen and monitoring. Some conversions require specialized methods. The safety task is to use an appropriate conversion approach with individualized adjustment, breakthrough planning, and prompt reassessment.
Apply it
A patient has adequate analgesia but persistent hallucinations during renal decline. Consider whether switching opioids could reduce toxicity, review total exposure and organ function, and arrange close reassessment rather than applying a conversion table as a complete prescription.
Common pitfall: Treating equianalgesic estimates as exact can cause overdose or poor relief. A universal conversion reduction is also unsafe across agents, especially when specialized conversion methods apply.
22.Which bowel regimen should accompany ongoing opioid therapy?
Opioids reduce intestinal propulsion and secretion, and tolerance to constipation generally does not develop. A concrete preventive choice is scheduled senna, a stimulant laxative, started with ongoing opioid treatment and titrated to comfortable bowel function. A stool softener such as docusate alone does not adequately address impaired propulsion; adding it to senna has not shown further benefit in the cited NCI review. If constipation persists, assess adherence, impaction, obstruction, and other causes; an osmotic agent such as polyethylene glycol may then be added or selected as appropriate.
Apply it
A patient beginning regular opioids has hard stools and limited mobility without obstructive symptoms. Start scheduled senna and arrange reassessment. If stools remain difficult despite an adequate trial, assess for impaction and other contributors before adding polyethylene glycol. New vomiting, marked distension, colicky pain, or absent flatus requires evaluation before routine laxative escalation.
Common pitfall: Docusate alone is not effective preventive treatment for opioid-related hypomotility. Persistent symptoms require assessment, especially when obstruction or impaction may explain apparent laxative failure.
23.How is breathlessness relieved when oxygenation is adequate?
Breathlessness treatment combines attention to reversible causes with measures directed at the experience of air hunger. Positioning, cool airflow, pacing, calm support, and appropriately selected systemic opioids may reduce distress. Supplemental oxygen is particularly relevant when hypoxemia is present, but a normal saturation does not exclude a need for symptom treatment. Assess response using the patient's comfort and respiratory distress, while monitoring adverse effects. Choose interventions by benefit, burden, and goals rather than saturation alone.
Apply it
A dying patient remains breathless despite adequate oxygenation and wants to avoid a tight mask. Offer comfortable positioning, airflow, reassurance, and appropriate medication assessment, then reassess reported air hunger rather than increasing oxygen solely because distress continues.
Common pitfall: A normal saturation does not justify withholding relief. Conversely, escalating oxygen without evidence of comfort benefit can add dryness, noise, and equipment burden for the patient.
24.Which supportive measures reduce delirium-related distress?
Supportive delirium care reduces unnecessary stimulation, promotes a calm familiar environment, supports orientation, and addresses sensory or communication barriers. Treat feasible contributors and assess pain, medication effects, and immediate safety. Familiar people and simple explanations may help, but arguing about misperceptions can increase distress. Medication decisions depend on the severity and cause of symptoms; routine sedation is not a substitute for assessment. The aim is comfort and safety while preserving meaningful interaction when achievable.
Apply it
A confused patient becomes frightened by unfamiliar staff and repeated room changes. Reduce interruptions, use a consistent calm approach, bring needed hearing support, and involve a trusted caregiver while investigating medication changes and other potentially reversible contributors.
Common pitfall: Repeatedly correcting every false belief may escalate fear. Automatically sedating a quiet confused patient can obscure the clinical change and reduce interaction without addressing its cause.
25.How should mouth care and hydration decisions be separated?
Dry mouth can often be relieved with regular mouth care, lip care, and small amounts of fluid when desired and safe. It does not automatically establish a need for clinically assisted hydration. Hydration decisions should consider the suspected cause of distress, possible benefit, fluid-related burdens, prognosis, and patient preferences. Evidence near death does not support promising that fluids will reliably improve comfort or prolong life. A time-limited trial can be considered when a specific benefit can be evaluated.
Apply it
A family requests intravenous fluids because the patient's lips appear dry. Assess thirst, oral condition, swallowing, and fluid-related risks. Provide mouth care immediately and discuss whether a hydration trial has a defined comfort goal that could justify its burdens.
Common pitfall: Using intravenous fluid as the default treatment for every dry mouth overlooks direct oral care. Automatically withholding fluids also bypasses individualized assessment of possible benefit.
26.How should noisy respiratory secretions near death be managed?
Noisy breathing near death may result when a patient can no longer clear upper airway secretions. The sound can distress relatives without demonstrating equivalent patient suffering. Assess observable comfort, explain the mechanism, and consider gentle repositioning and secretion-reducing treatment when appropriate. Antisecretory medicines limit further secretion production rather than removing material already present. Deep suctioning may be uncomfortable and may not offer sustained benefit. Management should prioritize the patient's comfort and realistic expectations about treatment effects.
Apply it
An unresponsive patient has noisy breathing without grimacing or increased respiratory effort. Explain the likely cause, assess comfort, and try gentle repositioning. Discuss limited treatment expectations rather than assuming repeated deep suctioning is needed to prevent suffocation.
Common pitfall: The loudness of breathing is not a validated measure of suffering. Promising that medication will immediately remove existing secretions misrepresents its mechanism and likely effect.
27.How does advanced chronic kidney disease change a noncancer symptom plan?
Advanced kidney disease changes medication clearance even when the symptom being treated is unrelated to cancer. Morphine metabolites can accumulate and produce neuroexcitation; gabapentin and pregabalin require renal adjustment, and NSAIDs can worsen renal injury. New somnolence or jerking therefore requires medication review alongside assessment for metabolic and other causes. When ongoing opioid treatment is necessary, a carefully selected alternative such as fentanyl may reduce problems from renally cleared active metabolites, but route, prior exposure, dose, and monitoring remain essential. These pharmacokinetic principles do not depend on a cancer diagnosis.
Apply it
A patient with advanced noncancer kidney disease and chronic musculoskeletal and neuropathic symptoms develops drowsiness and myoclonus while taking morphine and gabapentin. Urgently assess breathing and alertness, review and reduce or hold contributing treatment as clinically indicated, reassess renal dosing, and plan a monitored opioid switch if analgesia remains necessary. Check whether cognition and movements improve while comfort is maintained.
Common pitfall: Calling every cognitive change uremia can miss medication toxicity. Switching automatically to hydromorphone does not eliminate metabolite accumulation risk, and a fentanyl patch is not a universal replacement for every opioid regimen.
Cancer Pain (PDQ) — Health Professional Version · Last Days of Life (PDQ) — Health Professional Version
28.What immediate management follows suspected malignant spinal cord compression?
New neurologic or sphincter findings with concerning spinal pain require immediate specialist coordination when evaluation and treatment accord with goals. NICE NG234 recommends MRI as soon as possible and always within 24 hours for suspected MSCC; imaging includes whole-spine sequences. Assess promptly for dexamethasone: NICE recommends 16 mg orally, or equivalent parenterally, as soon as possible when neurologic symptoms or signs are present, followed by its specialist treatment pathway. These are NICE recommendations, not HPCC examination rules. Start spinal precautions without delay when instability is suspected, and coordinate radiology, oncology, and spinal surgery assessment.
Apply it
A patient with vertebral metastases develops leg weakness and urinary difficulty and wants function-preserving treatment. Contact the emergency MSCC service immediately, arrange urgent whole-spine MRI, assess corticosteroid treatment, and avoid unsupported transfers or weight bearing if instability is suspected. Provide analgesia while specialists determine surgery, radiotherapy, and safe positioning or mobilization.
Common pitfall: Do not wait for paralysis, rely on a normal plain radiograph, or substitute analgesic escalation for the emergency pathway. Neurologic MSCC and spinal pain without neurologic findings have different urgency and corticosteroid recommendations.
Recommendations | Spinal metastases and metastatic spinal cord compression | Guidance | NICE · HPCC 2026 ACHPN Candidate Handbook hosted by PSI
29.How does anticipatory planning improve care for catastrophic bleeding?
Before a major bleed occurs, clarify whether the patient wants hospital transfer and potentially hemostatic treatment or bedside comfort care for an overwhelming terminal hemorrhage. Prepare emergency contact numbers, dark towels, gloves, aprons, disposal bags, and prescribed rescue medication. Assign who will summon help, remain with the patient, and obtain supplies. During bleeding, remain calm, stay with and reassure the patient, summon agreed help, use dark towels to reduce the visual impact of blood, and apply direct pressure to an accessible bleeding point when appropriate. Rapidly administered prescribed sedation, such as midazolam, may relieve severe distress when feasible. Obtaining medication must not displace bedside presence.
Apply it
A patient with an ulcerating tumor declines transfer for a terminal bleed. Store the agreed supplies nearby and share the plan with family, community nurses, and the prescribing clinician. If brisk bleeding occurs, one caregiver stays beside the patient, speaks reassuringly, and holds a dark towel with pressure over the accessible bleeding site while another calls the agreed clinical service and brings prescribed rescue medication.
Common pitfall: Dark towels reduce visible blood but do not stop hemorrhage. Sedation relieves distress rather than controlling the bleeding itself, and a rapidly fatal event may leave little time for medication. Do not leave a frightened patient alone to search for supplies; preparation should allow reassurance and practical care to begin immediately.
Last Days of Life (PDQ) — Health Professional Version · HPCC 2026 ACHPN Candidate Handbook hosted by PSI · pall-care-emergencies-slides-1.pdf
30.When can palliative sedation be considered for refractory suffering?
Palliative sedation may be considered when intolerable suffering remains refractory despite appropriate assessment and treatment, or when further reasonable treatment cannot provide relief within an acceptable time or burden. Its clinical purpose is relief of suffering through a proportionate reduction in consciousness. Establish the refractory symptom, alternatives, consent process, goals, monitoring, and ongoing care. Severe distress alone does not establish refractoriness. Decisions about hydration or other treatments require their own evaluation rather than being automatically determined by sedation.
Apply it
A dying patient has intolerable breathlessness despite specialist review and appropriately attempted treatments. Discuss whether the symptom is refractory, explain the expected effect on consciousness, establish consent and monitoring, and consider proportionate sedation within a documented comfort plan.
Common pitfall: Family exhaustion alone does not establish an indication for sedating the patient. Sedation should not replace treatment of a readily reversible symptom or imply automatic withdrawal of other care.
31.How is comfort maintained during withdrawal of ventilation?
After confirming an informed, authorized decision, prepare medications, staff responsibilities, and family support before reducing ventilatory assistance. Give anticipatory opioid treatment for breathlessness and pain; add a benzodiazepine for anxiety when indicated. Individualize medication selection, dose, and timing to prior opioid and sedative exposure, organ function, current distress, and administration route. Establish comfort before withdrawal, then rapidly reassess and provide rescue treatment as support is reduced. Continue bedside observation afterward, using patient reports when possible and observing respiratory effort, facial tension, and agitation. Neuromuscular blockers provide neither analgesia nor relief of anxiety or air hunger; discontinue them and ensure their effects have resolved before withdrawal. These principles are addressed in the [ATS clinical statement](https://academic.oup.com/ajrccm/article/177/8/912/8517991).
Apply it
A patient requests withdrawal of burdensome ventilation. The team confirms the decision, explains expected changes and uncertain survival, and verifies that neuromuscular blockade has resolved. Before reducing support, administer an individualized opioid for anticipated air hunger and treat anxiety if present. A clinician remains at the bedside, reassesses after each change, and gives rapidly acting rescue medication for recurrent distress while supporting the family.
Common pitfall: Apparent stillness during paralysis cannot establish comfort because neuromuscular blockade suppresses movement without treating suffering. Do not wait for severe distress before administering anticipatory medication or use a fixed regimen regardless of tolerance and organ function. Titrate treatment to symptom relief and continue observation throughout withdrawal and afterward.
Last Days of Life (PDQ) — Health Professional Version · AMA Code of Medical Ethics: Withholding or Withdrawing Life-Sustaining Treatment
Education and Communication36/150 scored questions (24%, calculated)
32.How does teach-back reveal whether an explanation worked?
Teach-back asks the learner to explain important information in their own words so the clinician can assess the clarity of teaching. Present a small amount of information, use a nonjudgmental invitation, and listen for understanding and gaps. If the explanation is incomplete, reteach differently and check again. Asking whether the patient understands produces less useful evidence. Teach-back evaluates the communication process and helps tailor education; it should not feel like a test of intelligence or compliance.
Apply it
After explaining when to call for uncontrolled symptoms, ask a caregiver to describe what they would do if pain remains severe. Their response omits the contact number, so simplify the plan and repeat teach-back after showing where the number is recorded.
Common pitfall: Repeating the same jargon more loudly is not effective reteaching. A confident yes to an understanding question does not demonstrate that the learner can apply the information.
33.When is return demonstration more informative than verbal recall?
A practical skill requires evidence that the learner can perform it, not merely describe it. Demonstrate the task, invite the caregiver to show it back, and observe the steps that determine safety. Correct misunderstandings respectfully and repeat practice until the learner can perform the agreed task reliably. Physical limitations, vision, dexterity, and equipment design may explain difficulty. The response may require a different device or additional help rather than further verbal instruction alone.
Apply it
A caregiver correctly explains a liquid medication schedule but cannot read the measuring device or reliably draw up the prescribed amount. Observe a demonstration, adapt the equipment and teaching, and arrange another capable person if safe administration remains uncertain.
Common pitfall: Accurate verbal recall does not prove motor skill or visual ability. Treating repeated difficulty as inattentiveness can miss an equipment mismatch or a need for practical assistance.
34.How should teaching be adapted to readiness and developmental needs?
Effective teaching considers developmental stage, prior knowledge, language, sensory access, emotional readiness, fatigue, and the learner's immediate responsibilities. Prioritize a few actionable points, use plain language, and check understanding before adding complexity. Age alone does not establish learning ability or preferred detail. In serious illness, distress and exhaustion can narrow attention, so timing and repetition matter. Tailoring means changing the method and pace while preserving accurate information and the patient's desired participation in decisions.
Apply it
An exhausted caregiver struggles during a long discharge lesson. Teach the essential overnight actions first, provide a clear written plan, arrange a rested support person when possible, and verify understanding before covering less urgent background information at a later opportunity.
Common pitfall: A complete lecture is not necessarily successful education. Assuming that older adults cannot learn, or that younger caregivers need no support, substitutes stereotypes for individual assessment.
AHRQ Tool: Teach-Back · Communication in Cancer Care (PDQ) — Health Professional Version
35.How should an interpreter be incorporated into serious-illness discussions?
Use a qualified medical interpreter when language differences limit accurate communication. Speak directly to the patient, use short clear segments, and pause for interpretation and questions. Check understanding rather than assuming fluent conversation establishes comprehension of complex choices. Family members can provide support but may omit, alter, or filter sensitive information when serving as interpreters. Before a difficult discussion, clarify the interpreter's role and the patient's preferred participants while maintaining the patient's voice in the encounter.
Apply it
A bilingual relative offers to translate a prognosis discussion. Arrange a qualified interpreter, invite the relative to remain if the patient wishes, and address the patient directly while checking understanding of the treatment options and their consequences.
Common pitfall: Conversational fluency does not guarantee accurate interpretation of medical risk. Speaking to the interpreter instead of the patient can also diminish engagement and obscure the patient's own questions.
Communication in Cancer Care (PDQ) — Health Professional Version
36.How can serious news be delivered in manageable steps?
Prepare a private, supportive setting and establish what the patient already understands and wants to know. Give a clear warning that difficult information is coming, explain the central news in plain language, and pause. Respond to emotion before adding extensive detail, then check understanding and identify the next decision or support. Information delivered accurately but too rapidly may not be retained. A useful conversation combines clarity, emotional responsiveness, and a concrete plan for continued care.
Apply it
A patient expects another cancer treatment, but progression has removed that option. Ask what they understand, explain the change clearly, pause for their reaction, and then discuss what can still be done for symptoms and personally important goals.
Common pitfall: Listing technical findings before stating their meaning can obscure the news. Immediate reassurance or a rapid treatment lecture can also bypass the patient's emotional response.
Communication in Cancer Care (PDQ) — Health Professional Version
37.Why should emotion be acknowledged before more information is added?
Strong emotion can limit attention and make additional facts difficult to absorb. Acknowledge what is observable, invite the patient's perspective, and allow silence before continuing. Empathy does not require agreement with every interpretation or a promise of a favorable outcome. It communicates that distress has been heard and can reveal the concern driving a question. Once the patient is ready, connect the discussion to useful information and a practical next step rather than leaving the conversation at acknowledgment alone.
Apply it
After hearing that treatment is no longer helping, a patient says, 'You are giving up on me.' Acknowledge the fear and ask what feels most frightening before explaining the continuing commitment to symptom relief and support.
Common pitfall: Responding immediately with technical evidence may intensify the sense of abandonment. Promising that everything will be fine offers reassurance without addressing the actual fear or uncertainty.
Communication in Cancer Care (PDQ) — Health Professional Version
38.How can prognostic uncertainty be explained clearly?
Explain what is known, what remains uncertain, and how uncertainty affects planning. Use an understandable range when appropriate, describe the clinical signs informing the estimate, and discuss possible faster or slower courses. Ask how much detail the patient wants and what decisions depend on the answer. Pair uncertainty with preparation and continuing support. Saying that no one knows can be technically true yet unhelpful when an informed estimate and practical guidance are available.
Apply it
A caregiver asks whether relatives should travel now. Explain that the patient's decline makes time potentially short, acknowledge that exact timing is uncertain, and help the family weigh travel decisions against the possibility of a rapid change.
Common pitfall: A precise number may sound reassuring but imply certainty the evidence cannot support. Avoiding an estimate altogether can prevent timely decisions about visits, caregiving, and unfinished priorities.
Last Days of Life (PDQ) — Health Professional Version · Communication in Cancer Care (PDQ) — Health Professional Version
39.How should requests to withhold information from a patient be explored?
A family request to avoid discussing prognosis may reflect concern, cultural expectations, or fear of harming hope. Explore the reason respectfully, then establish the patient's own preferences for information and family involvement. Some patients want detailed disclosure; others prefer information to be shared through chosen relatives. Cultural humility requires asking rather than assigning a preference based on group membership. The patient's expressed wishes should guide the communication arrangement within applicable ethical and legal requirements.
Apply it
Relatives ask the team not to tell an alert patient that treatment has failed. Explore their concern, then ask the patient how they prefer medical information and decisions to be handled, without assuming either direct disclosure or family control is universally preferred.
Common pitfall: Automatically obeying relatives can exclude a patient who wants information. Automatically rejecting family involvement can also disregard a patient's chosen approach to receiving news and making decisions.
Communication in Cancer Care (PDQ) — Health Professional Version
40.How can cultural and spiritual practices be incorporated into care?
Ask patients and families which practices, relationships, rituals, or spiritual supports matter during illness and dying. Clarify the practical request and its meaning before assessing how it can be accommodated. Individuals vary within every cultural or religious group, and preferences may change with circumstances. Explain genuine clinical limitations respectfully and seek workable alternatives. The aim is a care plan that respects the person's values while making safety needs and available choices understandable to everyone involved.
Apply it
A family requests a ritual that involves several visitors near the bedside. Ask the patient about its importance, clarify the ritual's requirements, and coordinate a feasible arrangement that preserves comfort and necessary care while respecting the family's stated priorities.
Common pitfall: A cultural label does not predict an individual's wishes. Rejecting an unfamiliar practice before clarifying its requirements can create avoidable conflict and miss a feasible accommodation.
Communication in Cancer Care (PDQ) — Health Professional Version
41.How should a surrogate be prepared to represent the patient?
A surrogate needs more than a name on a document. Discuss the patient's values, prior statements, acceptable outcomes, and willingness to undergo burdens for possible benefit. Explain that the role is to represent the patient's preferences rather than select what the surrogate personally wants. Prepare for uncertainty by considering how values would guide unfamiliar scenarios. Including the surrogate while the patient can participate creates opportunities to correct misunderstandings and reduces reliance on guesswork during a crisis.
Apply it
A patient says being able to recognize family matters more than living as long as possible. Invite the chosen surrogate to explain how that value might guide a future decision about prolonged treatment, then let the patient clarify any misunderstanding.
Common pitfall: Asking only whether the surrogate agrees with the patient can conceal different interpretations. A procedure checklist may also fail when an unforeseen situation requires values-based judgment.
Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ)
42.How can a family meeting move beyond conflicting treatment demands?
Begin by clarifying participants, the patient's decision-making role, and the shared understanding of illness. Invite each person to explain concerns and what they believe the patient would value. Apparent disagreement about a procedure may reflect different prognostic assumptions, fear, guilt, or unresolved communication. Summarize common goals and explain how available options relate to those goals. A family meeting supports understanding and planning; it does not transfer authority away from a patient who can decide.
Apply it
Siblings disagree about hospitalization for their parent, who cannot currently participate. One expects recovery, while another believes death is near. Clarify the clinical outlook and the parent's prior wishes before asking them to choose between treatment settings.
Common pitfall: Voting among relatives can substitute family preference for the patient's values. Repeating recommendations without exploring different assumptions may leave the actual source of disagreement untouched.
Communication in Cancer Care (PDQ) — Health Professional Version · Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ)
43.What should families learn about expected changes during dying?
Prepare families for common changes in intake, alertness, urine output, breathing, and circulation while explaining that the sequence and timing vary. Distinguish expected changes from signs of discomfort and give concrete instructions about comfort measures and whom to contact. Invite questions about feared experiences, including choking, starvation, or abandonment. Education should reduce uncertainty without promising a fixed course. Revisit the explanation as changes occur, because information offered earlier may become meaningful only at the bedside.
Apply it
A family becomes alarmed when the patient's breathing becomes irregular. Explain the change in the context of the overall decline, assess for distress, review the comfort plan, and show the family how to reach help if symptoms become concerning.
Common pitfall: Calling every change normal without examining comfort can dismiss suffering. Giving a rigid sequence of dying signs can also make families fear that an expected variation is a crisis.
44.What distinguishes anticipatory grief from completed bereavement?
Anticipatory grief occurs in response to an expected loss and may include sadness, anxiety, changing roles, and concern about the future before death occurs. Patients and families may grieve different losses at different times. This experience does not guarantee that grief after death will be milder or already completed. Explore the person's specific losses, available support, coping, and practical needs. Support should follow the individual experience rather than require a particular emotional sequence or appearance.
Apply it
A partner feels guilty for grieving while the patient is still alive. Explain that expected loss and current role changes can evoke grief now, then explore support and practical worries without suggesting that bereavement after death has already been resolved.
Common pitfall: Assuming that early grief protects against later distress can reduce needed follow-up. Interpreting sadness before death as disloyalty also misunderstands a common response to threatened loss.
45.Why should grief support avoid a fixed stage timetable?
Grief varies in expression, intensity, duration, and cultural context. Feelings may recur or coexist rather than follow a universal sequence of stages. Assess the person's functioning, support, distress, and safety instead of judging progress by whether a prescribed stage has been reached. Significant impairment or concerning symptoms warrant further assessment, but crying, relief, anger, or temporary distraction alone does not determine pathology. Individualized support recognizes both the relationship lost and the person's broader circumstances.
Apply it
A bereaved adult alternates between sadness and enjoyment with friends and worries this means they are grieving incorrectly. Explain that variation is common, explore daily functioning and support, and assess concerns without assigning a required emotional stage.
Common pitfall: A fixed stage model can make normal variation seem like failure. Conversely, declaring all distress normal can obscure substantial impairment or a need for more focused assessment.
Professionalism and Practice38/150 scored questions (25.33%, calculated)
46.When may a patient refuse life-sustaining treatment?
A patient with decision-making capacity may decline or stop an intervention, including life-sustaining treatment, after an informed discussion of its implications. The decision need not match the clinician's recommendation or require that death be imminent. Clarify understanding, voluntariness, goals, and available alternatives, then document the decision and plan continuing care. Respecting refusal does not mean abandoning symptom management or support. Disagreement alone does not establish incapacity or justify transferring the decision to relatives.
Apply it
An informed patient with capacity declines further ventilatory support because its burdens conflict with personal goals. Confirm understanding and voluntariness, discuss comfort treatment, and coordinate the plan rather than requiring family agreement before recognizing the patient's decision.
Common pitfall: A clinician's belief that treatment is beneficial does not erase an informed refusal. Also avoid interpreting refusal of one intervention as refusal of all medical and nursing care.
AMA Code of Medical Ethics: Withholding or Withdrawing Life-Sustaining Treatment
47.Why are withholding and withdrawing treatment ethically equivalent?
Ethically, choosing not to start a life-sustaining treatment and choosing to stop it can rest on the same assessment of patient preferences, goals, benefits, and burdens. Starting a treatment does not create a permanent obligation to continue it when it no longer serves the agreed goals. Explain this before uncertain treatments begin when possible. The decision process should remain careful and documented, and comfort care continues whether treatment is withheld, continued, or withdrawn.
Apply it
A family accepts a ventilator trial but fears it can never be stopped once started. Explain that response and the patient's goals can be reassessed, and that withdrawal may be ethically appropriate if the trial fails to provide the intended benefit.
Common pitfall: Treating withdrawal as inherently unethical can trap patients in unwanted burdens. Ethical equivalence also does not eliminate the need for consent, preparation, and a continuing comfort plan.
AMA Code of Medical Ethics: Withholding or Withdrawing Life-Sustaining Treatment
48.How should a time-limited treatment trial be defined?
A time-limited trial offers treatment under uncertainty with an agreed clinical goal, meaningful indicators of response, a reassessment point, and a plan for decisions if goals are not met. It is more than an open-ended promise to try everything. The endpoints should reflect outcomes the patient values, not merely an isolated physiologic improvement. Discuss possible continuation, modification, or withdrawal in advance, while acknowledging that new information may require a renewed conversation rather than a mechanical rule.
Apply it
A patient accepts intensive treatment only if it offers a reasonable path back to meaningful interaction. Define observable improvement, a review interval, and options if recovery remains unlikely instead of leaving continuation dependent solely on whether blood pressure improves.
Common pitfall: A trial without endpoints can become indefinite treatment by default. Conversely, a calendar deadline should not replace interpretation of new evidence and the patient's stated goals.
AMA Code of Medical Ethics: Withholding or Withdrawing Life-Sustaining Treatment
49.How do substituted judgment and best interests differ?
When a patient cannot decide, prior expressed preferences and values should guide the surrogate's representation of what the patient would choose. This is substituted judgment. If relevant preferences are unknown, a best-interests approach considers expected benefits, burdens, suffering, and the patient's circumstances. The surrogate's personal preference is not automatically the patient's preference. Clarify available evidence and seek ethics support for unresolved disagreement, especially when a proposed choice appears inconsistent with the patient's known goals or welfare.
Apply it
A patient cannot participate, but prior conversations clearly rejected prolonged dependence without awareness. Help the surrogate apply those values. For another patient with no known preferences, structure the discussion around likely benefits, burdens, and comfort rather than inventing wishes.
Common pitfall: Asking what the surrogate wants can shift the decision away from the patient. Also avoid claiming substituted judgment when no meaningful evidence of the patient's preferences exists.
AMA Code of Medical Ethics: Withholding or Withdrawing Life-Sustaining Treatment
50.How do professional boundaries protect a therapeutic relationship?
Professional boundaries keep the relationship centered on the patient's needs and preserve appropriate responsibility, access, and accountability. Serious illness can create intense closeness, but dependence, exclusivity, personal benefit, or secrecy may signal a boundary concern. Respond warmly while using established team communication and support structures. When a request exceeds the professional role, explain the limit and offer an appropriate alternative. Therapeutic presence and compassion are compatible with limits that protect both continuity and fair access to care.
Apply it
A caregiver asks for the clinician's private number and insists that only this clinician can help. Explore the unmet need, explain the team's reliable contact arrangements, and strengthen continuity rather than creating an exclusive private channel outside established care.
Common pitfall: Equating unlimited personal availability with compassion can undermine team care and increase dependence. Abrupt distancing without an alternative can also feel abandoning and leave a real need unresolved.
2025 Code of Ethics for Nurses Provision 2.3 · HPCC 2026 ACHPN Candidate Handbook hosted by PSI
51.How does certification relate to APRN scope of practice?
Specialty certification recognizes defined knowledge and competence but does not independently determine every activity an APRN may perform. Practice authority also depends on jurisdictional licensure, role preparation, applicable law, organizational privileges, and demonstrated competence for the task. ACHPN includes eligible NPs and CNSs, whose legal authority may differ by location and role. Before undertaking an unfamiliar intervention, identify the specific authority and competency requirements rather than assuming the credential grants universal prescribing or procedural permission.
Apply it
An ACHPN-certified CNS moves to a new jurisdiction and is asked to prescribe independently. Confirm the local CNS licensing and prescribing requirements and organizational authorization before accepting the task, even though the clinician has relevant specialty knowledge.
Common pitfall: A national credential does not erase jurisdictional restrictions. Employer willingness to assign a task also does not, by itself, establish legal authority or individual competence.
HPCC 2026 ACHPN Candidate Handbook hosted by PSI · ACHPN | HPCC
52.What emergency sequence should naloxone counseling teach?
Naloxone competitively antagonizes opioid receptors and can reverse opioid-related respiratory depression. Its effect may wear off before the opioid's effect, so breathing can deteriorate again after initial improvement. For the cited NARCAN 4 mg nasal product, give one spray into one nostril, obtain emergency medical help immediately, and monitor breathing and responsiveness. If response is inadequate or respiratory depression recurs, repeat every 2–3 minutes using a new device and alternating nostrils, following its instructions. Provide supportive or resuscitative measures as indicated while help is coming. Each device contains one dose; do not prime or reuse it.
Apply it
A caregiver finds an opioid-treated patient unresponsive with very slow breathing. Administer the available NARCAN nasal dose, call emergency services, monitor and support breathing, and use a new device after 2–3 minutes if response is inadequate or depression recurs. Improvement after the first dose does not cancel the emergency call.
Common pitfall: Naloxone does not make unsafe medication combinations safe or replace emergency care. Abrupt reversal may precipitate withdrawal and loss of analgesia, but recurrence risk still requires observation and repeat rescue treatment when indicated.
FDA recommends discussing naloxone when prescribing opioid medicines · DailyMed - NARCAN- naloxone hydrochloride spray
53.Why does opioid storage belong in the care plan?
Opioid safety includes preventing accidental ingestion, unauthorized use, and diversion while preserving timely access for legitimate treatment. Discuss secure storage, who is responsible for administration, keeping medicines away from children and visitors, and appropriate disposal of unused medication. Tailor arrangements to the household rather than assuming a written prescription controls access. Education should be practical and nonjudgmental. Naloxone availability and a clear emergency response plan add protection but do not replace safe storage and administration.
Apply it
A patient keeps opioid medicine on a kitchen counter while young grandchildren visit regularly. Work with the household to establish secure storage and a responsible administration routine that protects children without making prescribed symptom relief inaccessible to the patient.
Common pitfall: Hiding medication in an unlocked drawer may not prevent access. Restricting access so severely that needed doses are repeatedly missed can also undermine the intended safety plan.
FDA recommends discussing naloxone when prescribing opioid medicines
54.How should opioid stewardship preserve analgesia while reducing harm?
Opioid stewardship pairs a clear indication and individualized goals with reassessment of analgesia, function, adverse effects, medication exposure, and overdose risks. Serious cancer pain may justify opioid treatment, while renal decline, sedation, or interacting depressants can require changes in the plan. Stewardship is an ongoing clinical process rather than a single screening label. Distinguish inadequate relief, toxicity, access problems, and concerning use patterns because each requires a different response and should not automatically lead to the same action.
Apply it
A patient's pain remains severe because the pharmacy could not supply the prescribed medicine. Confirm actual access before labeling the regimen ineffective or interpreting repeated calls as misuse, while still reviewing safety and arranging a feasible treatment plan.
Common pitfall: A risk label should not replace assessment of the current problem. Conversely, a palliative diagnosis does not eliminate overdose risk, medication interactions, or the need for follow-up.
Cancer Pain (PDQ) — Health Professional Version · FDA recommends discussing naloxone when prescribing opioid medicines
55.How should evidence be applied beyond the population studied?
Before applying a recommendation, identify the source population, clinical setting, outcome, evidence strength, and relevance to the patient's goals. Cancer-focused evidence may inform care but does not automatically establish identical effects in every noncancer illness. Evidence summaries also differ from binding regulation or formal organizational policy. Combine applicable evidence with clinical assessment and transparent discussion of uncertainty. The purpose is a reasoned decision, not attaching a respected source name to an unsupported extension of its conclusions.
Apply it
A team considers a cancer-derived symptom intervention for a patient with advanced organ failure. Examine whether the mechanism, risks, and desired outcome are comparable, then explain the remaining uncertainty and define how benefit and harm will be reassessed.
Common pitfall: An authoritative source does not support every claim in its topic area. Treating an evidence review as a universal mandate can obscure population differences and patient preferences.
Cancer Pain (PDQ) — Health Professional Version · Last Days of Life (PDQ) — Health Professional Version
56.How does moral distress call for organizational action?
Moral distress can arise when clinicians perceive an ethically appropriate action but encounter constraints that prevent it. Individual reflection, peer support, and self-care may help, but persistent system barriers require an organizational response. Identify the ethical concern, examine contributing policies or power structures, and use appropriate leadership, ethics, or reporting channels. Psychological support and practice improvement can proceed together. Framing every episode as personal fragility misses the responsibility to create conditions that enable ethical care.
Apply it
Nurses repeatedly report that staffing constraints prevent timely relief of distress. Offer support, document the recurring care problem, and engage leadership in a workable response rather than making resilience training the sole intervention for an ongoing system barrier.
Common pitfall: Self-care alone cannot correct an unsafe or ethically obstructive system. Equally, naming moral distress without examining the specific constraint does not identify a practical route to improvement.
ANA Position Statement: Nurses' Professional Responsibility to Promote Ethical Practice Environments
57.Which measures show whether a quality project changes patient care?
A useful quality project links a defined problem to measurable processes and patient-relevant outcomes. A process measure shows whether a care step occurred; an outcome measure shows whether the desired result changed. Use consistent definitions, an appropriate denominator, and a baseline for comparison. Education attendance alone does not demonstrate improved symptom relief. Measures should help the team determine whether the intervention was implemented and whether patients experienced the intended benefit, while identifying important unintended burdens.
Apply it
A hospice introduces a pain follow-up pathway. Track both the proportion of eligible episodes receiving reassessment and the proportion with improved comfort. These measures distinguish reliable completion of the new process from the outcome the process is intended to improve.
Common pitfall: Counting completed forms can mistake documentation for better care. Changing the denominator between periods can also create apparent improvement that reflects measurement differences rather than clinical change.
58.How should improvement be evaluated after a practice change?
Evaluation compares performance over time using stable definitions and examines whether improvement is sustained, clinically meaningful, and plausibly related to the change. Review implementation, patient mix, missing data, and unintended effects before concluding success. A single favorable month can reflect chance or a different population. Use findings to refine the intervention and continue monitoring. Quality improvement requires evidence that the action worked in practice, not merely that a policy was approved or staff received instructions.
Apply it
After a new symptom pathway, documented reassessment rises sharply, but caregivers report longer callback delays. Examine both trends and the underlying workflow, then adapt the pathway so improved documentation does not conceal a deterioration in timely access.
Common pitfall: Declaring success after one favorable data point can miss unstable performance. Focusing only on the target measure can also conceal harms created elsewhere in the care process.
59.What establishes eligibility for the U.S. Medicare hospice benefit?
For the U.S. Medicare hospice benefit, the central prognosis criterion is a life expectancy of six months or less if the terminal illness follows its normal course, supported by required physician certification. The patient elects the hospice benefit under its coverage rules. This is a prognosis-based benefit, not a requirement to die within six months. Continued eligibility depends on appropriate recertification and clinical support for the prognosis. These rules should not be generalized to every country, payer, or palliative service.
Apply it
A patient remains alive eight months after hospice election but continues to have a supported prognosis of six months or less if the illness follows its normal course. Evaluate recertification requirements rather than assuming survival beyond six months automatically ends eligibility.
Common pitfall: Six months is a prognostic criterion, not a fixed maximum length of stay. A diagnosis or low performance score alone also does not replace the required certification process.
60.How should professional development address a demonstrated practice gap?
Professional development is strongest when it begins with a specific gap in knowledge, judgment, or performance and ends with reassessment of practice. Use feedback, case review, outcome data, and reflection to identify the need. Select learning that targets the gap, apply it with appropriate support, and evaluate whether decisions or care improve. Completing an educational activity demonstrates participation; it does not alone establish procedural competence or reliable transfer of learning to complex patient situations.
Apply it
Case review shows repeated difficulty recognizing opioid toxicity during renal decline. Choose focused learning and supervised case discussion, then review subsequent prescribing and reassessment decisions to determine whether recognition and management have improved in actual practice.
Common pitfall: Accumulating unrelated education can leave a known clinical gap unchanged. A completion certificate also should not be treated as automatic evidence of competence for an unfamiliar clinical task.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Use the full 2026 HPCC outline and task statements to extend this selective guide, including further disease-specific care, superior vena cava syndrome, procedures, complementary approaches, life-support devices, and population-specific needs.
- Spend approximately 29% of review time on Assessment and Data Collection, 21% on Intervention and Management, 24% on Education and Communication, and 25% on Professionalism and Practice, then adjust for demonstrated gaps.
- Practise separating pain progression, incident pain, end-of-dose failure, and opioid toxicity using timing, neurologic findings, organ function, and treatment response.
- Link each proposed investigation or intervention to a patient-valued outcome, expected burden, time to benefit, and reassessment criterion.
- Rehearse serious-news conversations, qualified interpreter use, teach-back, surrogate preparation, and responses to grief without relying on scripts or fixed stages.
- Keep U.S. Medicare hospice rules distinct from palliative care access, professional certification, and jurisdiction-specific APRN authority.
A practical preparation plan
1. Map the complete outline
Create a study map using all four official domains and their subtopics. Mark which areas these 60 concepts address and identify additional disease-specific, procedural, emergency, and population-specific topics requiring study.
2. Work through assessment-to-action cases
For each case, state the decisive findings, plausible alternatives, patient goal, proposed action, and evidence of benefit or harm you would reassess. Give special attention to changes that alter urgency.
3. Practise communication aloud
Rehearse a prognosis discussion, an interpreter-supported conversation, a surrogate preparation discussion, and a caregiver skill demonstration. Check whether your wording produces understanding and an actionable plan.
4. Complete the independent drills
Answer the 20 questions before reading explanations. For every missed or uncertain response, identify the discriminating cue and explain why each alternative fits less well. Use the flashcards later for spaced recall.
5. Close gaps with the right source
Use the handbook to confirm examination scope, clinical references to support treatment principles, CMS for Medicare hospice requirements, and the relevant jurisdiction's rules for practice authority. Revisit uncertain conclusions rather than memorizing unsupported generalizations.
6. Reassess readiness by domain
Return to weak domains with new cases and explain decisions without notes. Review the applicable handbook and testing instructions before the appointment, particularly if testing under an outline later than the selected 2026 edition.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ACHPN | HPCC
- 2026 ACHPN Candidate Handbook — December 2025
- HPCC 2026 ACHPN Candidate Handbook hosted by PSI
- Cancer Pain (PDQ) — Health Professional Version
- Delirium: Cancer Treatment Side Effect
- Questions and Answers, Instructions and Definitions for Use of PPSv2 — July 2020
- Last Days of Life (PDQ) — Health Professional Version
- Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ)
- AHRQ Tool: Teach-Back
- Communication in Cancer Care (PDQ) — Health Professional Version
- Grief, Bereavement, and Coping With Loss (PDQ)
- FDA recommends discussing naloxone when prescribing opioid medicines
- AMA Code of Medical Ethics: Withholding or Withdrawing Life-Sustaining Treatment
- CMS: Hospice
- CMS State Operations Manual, Appendix M — Hospice
- ANA Position Statement: Nurses' Professional Responsibility to Promote Ethical Practice Environments
- bp102c09.pdf
- 2025 Code of Ethics for Nurses Provision 2.3
- DailyMed - NARCAN- naloxone hydrochloride spray
- Recommendations | Spinal metastases and metastatic spinal cord compression | Guidance | NICE
- Pain_Provider_AD_Quick_Reference_Guide.pdf
- Ethics Opinion: Decisions for Adult Patients Who Lack Capacity | AMA Code of Medical Ethics
- Recommendations | Decision-making and mental capacity | Guidance | NICE
- 7 Treating status epilepticus, repeated or cluster seizures, and prolonged seizures | Epilepsies in children, young people and adults | Guidance | NICE
- pall-care-emergencies-slides-1.pdf
- 5.3.pdf
- palliative-care.pdf
- End of Life Care - Living with the Risk of Bleeding :: Northern Care Alliance
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.